Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
Sci. STKE, 4 April 2006 EDITORS' CHOICEIMMUNOLOGY Accentuate the PositiveThe cytokine interleukin-2 (IL-2) facilitates proliferation of naïve T cells, but several studies have shown that antibodies that bind IL-2, which at first glance should be inhibitory, can promote the expansion of subsets of memory CD8+ T cells. Thus, IL-2 might somehow be inhibiting suppressive T cell populations that would otherwise prevent memory CD8+ T cell expansion. Boyman et al. (see the Perspective by Prlic and Bevan) now show that, instead, binding of antibodies to IL-2 augments the direct activity of the cytokine on memory CD8+ T cells themselves. Immune complexes form that focus local levels of IL-2 through presentation by Fc receptors. These observations could be important to consider in therapies that involve the manipulation of IL-2 and other cytokines, such as bone marrow transplantation and tumor immunotherapy. O. Boyman, M. Kovar, M. P. Rubinstein, C. D. Surh, J. Sprent, Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311, 1924-1927 (2006). [Abstract] [Full Text] M. Prlic, M. J. Bevan, An antibody paradox, resolved. Science 311, 1875-1876 (2006). [Summary] [Full Text]
Citation: Accentuate the Positive. Sci. STKE 2006, tw117 (2006). |
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882